ProQR Therapeutics (PRQR) Notes Payables (2021)

ProQR Therapeutics' Notes Payables history spans 1 years, with the latest figure at $5.5 million for Q4 2021.

  • For Q4 2021, Notes Payables changed N/A year-over-year to $5.5 million; the TTM value through Dec 2021 reached $5.5 million, changed N/A, while the annual FY2021 figure was $5.6 million, N/A changed from the prior year.
  • Notes Payables for Q4 2021 was $5.5 million at ProQR Therapeutics.
  • Across five years, Notes Payables topped out at $5.5 million in Q4 2021 and bottomed at $5.5 million in Q4 2021.